Answers are grounded in this paper and cite their sources.
1.1. Aim: To investigate the association of stereotactic radiosurgery (SRS) plus immunotherapy with overall survival (OS) compared to 3-5 fractions of stereotactic radiation therapy (SRT) plus immunotherapy in patients with brain metastases (BMs) from breast cancer, non-small cell lung cancer (NSCLC), and melanoma.
No takes yet. Share an insight, caveat, or question.
Amin et al. (2023) studied this question.
Synapse has enriched 8 related papers. Consider them for comparative context: